Print

Lay Description

This study is to confirm the efficacy and safety of intravenous terlipressin versus placebo in the treatment of adult subjects with hepatorenal syndrome (HRS) Type 1.

Category

  • Family Health
IRB Number
20170588HU
NCT Number
ct.gov registration not required
Open to Enrollment
No

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

Exclusion Criteria

Study Design

Arm Groups

Study Contact


Diana Anzueto Guerra
(210) 567-5225
anzuetod@uthscsa.edu

Alice Gong
(210) 567-5227
gong@uthscsa.edu

Diana Anzueto Guerra
(210) 567-5225
anzuetod@uthscsa.edu

Principal Investigator
Alice Gong